Reproducible Risk Loci and Psychiatric Comorbidities in Anxiety: Results from ~200,000 Million Veteran Program Participants
Daniel F. LeveyiD, Joel E. GelernteriD, Renato A PolimantiiD, Hang ZhouiD, Zhongshan ChengiD, Mihaela AslaniD, Rachel M. Quaden, John ConcatoiD, Krishnan RadhakrishnaniD, Julien BryoisiD, Patrick F. SullivaniD, Million Veteran Program, Murray B. SteiniD
Abstract
We used GWAS in the Million Veteran Program sample (nearly 200,000 informative individuals) using a continuous trait for anxiety (GAD-2) to identify 5 genome-wide significant (GWS) signals for European Americans (EA) and 1 for African Americans. The strongest findings were on chromosome 3 (rs4603973, p=7.40x10-11) near the SATB1 locus, a global regulator of gene expression and on chromosome 6 (rs6557168, p=1.04x10-9) near ESR1 which encodes estrogen receptor . A locus identified on chromosome 7 near MADIL1 (p=1.62x10-8) has been previously identified in GWAS of bipolar disorder and of schizophrenia and may represent a risk factor for psychiatric disorders broadly. SNP-based heritability was estimated to be ~6% for GAD-2. We also GWASed for self-reported anxiety disorder diagnoses (N=224,330) and identified two GWS loci, one (rs35546597, MAF=0.42, p=1.88x10-8) near the AURKB locus, and the other (rsl0534613, MAF=0.41, p=4.92x10-8) near the IQCHE and MADIL1 locus identified in the GAD-2 analysis. We demonstrate reproducibility by replicating our top findings in the summary statistics from the Anxiety NeuroGenetics Study (ANGST) and a UK Biobank neuroticism GWAS. We also replicated top findings from a large UK Biobank preprint, demonstrating stability of GWAS findings in complex traits once sufficient power is attained. Finally, we found evidence of significant genetic overlap between anxiety and major depression using polygenic risk scores, but also found that the main anxiety signals are independent of those for MDD. This work presents novel insights into the neurobiological risk underpinning anxiety and related psychiatric disorders. SignificanceAnxiety disorders are common and often disabling. They are also frequently co-morbid with other mental disorders such as major depressive disorder (MDD); these disorders may share commonalities in their underlying genetic architecture. Using one of the largest homogenously phenotyped cohorts available, the Million Veteran Program sample, we investigated common variants associated with anxiety in genome-wide association studies (GWASes), using survey results from the GAD-2 anxiety scale (as a continuous trait, n=199,611), and self-reported anxiety disorder diagnosis (as a binary trait, n=224,330). This largest GWAS to date for anxiety and related traits identified numerous novel significant associations, several of which are replicated in other datasets, and allows inference of underlying biology.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 288
- FWCI
- 24.88
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of Novel Genomic Loci for Anxiety and Extensive Genetic Overlap with Psychiatric Disorders
Markos Tesfaye, Piotr Pawel Jaholkowski, … Ole A. Andreassen·medRxiv·Sep 1, 2023
- Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling
Nora I. Strom, Brad Verhulst, … Ted Reichborn‐Kjennerud·Nature GeneticsPeer-reviewed·Feb 1, 2026
- A major role for common genetic variation in anxiety disorders
Kirstin Lee Purves, Jonathan R. I. Coleman, … Thalia Catherine Eley·Molecular PsychiatryPeer-reviewed·Nov 20, 2019
- Gene Discovery and Biological Insights into Anxiety Disorders from a Multi-Ancestry Genome-wide Association Study of >1.2 Million Participants
Eleni Friligkou, Solveig Løkhammer, … Renato A Polimanti·medRxiv·Feb 14, 2024
- Genome-wide analyses of quantitative generalised anxiety symptom severity
Megan Skelton, Brittany L. Mitchell, … Thalia Catherine Eley·medRxiv·Jul 10, 2025
- Genome-wide genetic overlap between fear-based disorders and generalised anxiety disorder
Abigail ter Kuile, Brittany L. Mitchell, … Thalia Catherine Eley·Molecular PsychiatryPeer-reviewed·Jun 29, 2026